序号 |
标题 |
次数 |
作者 |
发布时间 |
85321 |
DOTA-cyclic RDG(cRGD) 双功能螯合剂DOTA修饰环肽RDG |
98 |
zyl |
2024-11-26 |
85322 |
NOTA-CREKA 双功能螯合剂NOTA偶联CREKA五肽 |
106 |
zcy |
2024-11-26 |
85323 |
NOTA-PEG4-EDBp , NOTA偶联EDBp靶向肽 |
100 |
kx |
2024-11-26 |
85324 |
G5-CD/Ad-G3 CSTDs |
103 |
wyh |
2024-11-26 |
85325 |
DOTA-TMTP1 TMTP1偶联双功能螯合剂1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸(DOTA) |
89 |
zcy |
2024-11-26 |
85326 |
DOTA-Cy5.5-PS; DOTA-Cy5.5-聚苯乙烯 |
103 |
wyh |
2024-11-26 |
85327 |
AlF-NOTA-E[c(RGDfK)]2 ,环状螯合剂1,4,7-三氮杂环壬烷-1,4,7-三乙酸偶联二聚RGD肽 |
196 |
kx |
2024-11-26 |
85328 |
FITC/NOTA-[RM26] FITC荧光素标记螯合剂NOTA缀合RM26多聚体 |
177 |
zcy |
2024-11-26 |
85329 |
钆(Gd)金属配合物(Gd-DOTA) |
300 |
wyh |
2024-11-26 |
85330 |
SPIO-PEG2000-NOTA ,超顺磁性氧化铁表面偶联NOTA大环配体 |
175 |
kx |
2024-11-26 |
85331 |
NOTA-P-L-Lys6-GnRH 螯合剂NOTA缀合GnRH多肽衍生物 |
80 |
zcy |
2024-11-26 |
85332 |
脂肪酸修饰的ODDA-Sgc8-c |
94 |
wyh |
2024-11-26 |
85333 |
NIR分子探针Cy7-KCCGRRAGGSC |
148 |
zcy |
2024-11-26 |
85334 |
NOTA-PEG4-E[c(RGDfK)]2) ,大环配体NOTA偶联环肽 |
95 |
kx |
2024-11-26 |
85335 |
NOTA-DGL 大环NOTA修饰DGL纳米探针 |
126 |
zcy |
2024-11-26 |
85336 |
NOTA-DGL ,靶向分子探针前体 |
91 |
kx |
2024-11-26 |
85337 |
S-2-(4-异硫基)-1,4,7-三氮杂环壬烷-1,4-二羧酸 p-SCN-NODA |
107 |
zcy |
2024-11-26 |
85338 |
NOTA-RGD2 NOTA偶联精氨酸-甘氨酸-天冬氨酸(Arginine-Glycine-Aspartic,RGD) |
142 |
zcy |
2024-11-26 |
85339 |
NOTA-PEG7-H-Tz , NOTA-七聚乙二醇-H-四嗪 |
105 |
kx |
2024-11-26 |
85340 |
AE105-NOTA-click-Cy5 PET/光学双模态分子探针 |
115 |
zcy |
2024-11-26 |
85341 |
NOTA-PEG4-LLP2A , 双官能螯合剂NOTA修饰肽模拟配体LLP2A |
126 |
kx |
2024-11-26 |
85342 |
NOTA-PEG6-TATE NOTA-六聚乙二醇-奥曲肽 |
111 |
zcy |
2024-11-26 |
85343 |
内酰胺桥环化肽NOTA-GGNle-CycMSH(hex) |
109 |
kx |
2024-11-26 |
85344 |
NOTA-MAL-R9-FSH1 NOTA-马来酰亚胺-R9修饰的FSH1多肽 |
87 |
zcy |
2024-11-26 |
85345 |
NOTA-Bn-SCN-Aoc-BN(7-14) , S-2-(4-异硫氰基苄基)-NOTA偶联8-氨基辛酸(Aoc)-BN(7-14) |
97 |
kx |
2024-11-26 |
85346 |
NOTA-Folate 大环配体NOTA修饰叶酸 |
113 |
zcy |
2024-11-26 |
85347 |
Cy7.5-HER2-Nb;荧光分子Cy7.5标记HER2纳米抗体探针 |
69 |
wyh |
2024-11-26 |
85348 |
NOTA-MAL-FSH2-Lytic NOTA-马来酰亚胺修饰多肽FSH2-Lytic |
95 |
zcy |
2024-11-26 |
85349 |
NOTA-TRC105 ,双功能螯合剂标记TRC105嵌合单克隆抗体 |
126 |
kx |
2024-11-26 |
85350 |
NOTA-G3-cCNGRC 大环配体NOTA修饰G3-NGR环肽二聚体 |
222 |
zcy |
2024-11-26 |
85351 |
NOTA-PRGD2 大环配体NOTA偶联多肽PRGD2 |
128 |
zcy |
2024-11-26 |
85352 |
NOTA-PSMA-Cy5 NOTA偶联荧光标记PSMA核酸适体 |
111 |
zcy |
2024-11-26 |
85353 |
NOTA-PRGD2 , 二聚体环状RGDyK肽 |
112 |
kx |
2024-11-26 |
85354 |
NOTA-B11 NOTA偶联B11纳米抗体 |
81 |
zcy |
2024-11-26 |
85355 |
G5.NHAc-DOTA(Gd) Gd-DOTA修饰第五代聚酰胺胺树状大分子G5 |
120 |
zyl |
2024-11-26 |
85356 |
cas:149206-86-0, Dota-gly-gly-gly-(4-nitrophenyl)alanine amideAlfatide II(NOTA-E[PEG4-c(RGDfk)]2)) |
164 |
kx |
2024-11-26 |
85357 |
DOTA-c(RGDyK) |
146 |
kx |
2024-11-26 |
85358 |
cas:437608-50-9 ,Lutetium Lu177-DOTA-TATE |
136 |
kx |
2024-11-26 |
85359 |
p-NH2-Bn-PCTA的结构与组成、功能与应用 |
163 |
kx |
2024-11-26 |
85360 |
Deferoxamine-maleimide的功能与应用 |
109 |
kx |
2024-11-26 |
85361 |
NH2-PEG-DOTA-PEG-NH2;氨基-聚乙二醇-DOTA-聚乙二醇-氨基 |
89 |
wyh |
2024-11-26 |
85362 |
Fe3O4-PEG-DOTA NPs ;大环配体DOTA修饰性氧化铁纳米颗粒 |
124 |
wyh |
2024-11-26 |
85363 |
DBCO-PEG4-BODIPY 二苯基环辛炔-四聚乙二醇-氟硼二吡咯 |
146 |
zyl |
2024-11-26 |
85364 |
G5-CD/Ad-G3-DOTA CSTD;Gd螯合剂DOTA偶联金刚烷修饰环糊精的氨基末端的第五代核组分树状大分子 |
98 |
wyh |
2024-11-26 |
85365 |
p-NH2-Bn-DTPA-penta (t-Bu ester) |
92 |
kx |
2024-11-26 |